<DOC>
	<DOCNO>NCT00510367</DOCNO>
	<brief_summary>The goal clinical research study learn result multimodality ( chemotherapy , surgery radiation therapy ) treatment primary breast cancer occur time pregnancy . Researchers want evaluate outcome labor delivery well evaluate long-term health outcome child expose chemotherapy mother 's womb .</brief_summary>
	<brief_title>Primary Breast Cancer Occurring Concomitant With Pregnancy</brief_title>
	<detailed_description>Patients study evaluate Department Breast Medical Oncology attend physician obstetrician . Patients obstetrician referred obstetrician Maternal-Fetal Medicine specialist evaluation . Counseling primary breast cancer risk , stag evaluation , breast cancer management provide member Department Breast Medical Oncology . Counseling fetal health risk provide medical oncologist obstetrician Maternal-Fetal Medicine Specialist . Counseling surgical risk provide Breast Surgical Service . Evaluation include medical history physical exam . Doctors evaluate patient especially presence metastatic disease . The date last menstrual period estimate date delivery record . Patients study chest radiograph appropriate fetal shielding . Patients ultrasound abdomen evaluate presence absence metastatic disease liver . If suspicious abnormality find , MRI abdomen do . Scanning MRI thoracic spine perform screen bone metastasis . Patients standard blood test mammogram ultrasound affect breast lymph node bear area . Patients tissue biopsy confirm status cancer . An ultrasound also perform learn age development fetus . Patients operable primary breast cancer tumor surgical evaluation surgical therapy modify radical mastectomy segmental mastectomy lymph node dissection . Patients locally advance breast cancer receive systemic multi-agent chemotherapy presurgical setting . Patients physical exam , mammogram , ultrasound repeat evaluate tumor response treatment . All patient receive chemotherapy offer systemic chemotherapy 5-fluorouracil , doxorubicin , cyclophosphamide ( FAC ) . Patients follow 6-12 month use American Society Clinical Oncology Guidelines Surveillance Committee Guidelines . All child follow adulthood . If disease get bad , patient treat study individualized therapy . Premedication provide patient order decrease risk nausea vomit . When need , adjustment dosage chemotherapy modification way medicine give make order decrease side effect . This investigational study . The FDA approve study drug . Their use together study experimental . At least 100 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Â· All patient primary breast cancer occur pregnancy eligible enrollment . Patients present systemic metastasis time diagnosis . Patients unwilling unable give inform consent . Patients receive radiation therapy pregnant Patients receive chemotherapy first trimester pregnancy chemotherapy FAC .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>FAC</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Adriamycin</keyword>
	<keyword>Rubex</keyword>
	<keyword>5-Fluorouracil</keyword>
	<keyword>5-FU</keyword>
	<keyword>Adrucil</keyword>
	<keyword>Efudex</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Cytoxan</keyword>
	<keyword>Neosar</keyword>
	<keyword>Pregnancy</keyword>
</DOC>